Status: current, Defined. Date: 31-May 2022. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4711381000168118 | Prolanza (olanzapine 2.5 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4711391000168115 | Prolanza 2.5 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Prolanza 2.5 mg tablet | Is a | Prolanza | true | Inferred relationship | Some | ||
Prolanza 2.5 mg tablet | Is a | olanzapine 2.5 mg tablet | true | Inferred relationship | Some | ||
Prolanza 2.5 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Prolanza 2.5 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
Prolanza 2.5 mg tablet | has intended active ingredient | olanzapine | true | Inferred relationship | Some | 917926357 | |
Prolanza 2.5 mg tablet | has Australian BoSS | olanzapine | true | Inferred relationship | Some | 917926357 | |
Prolanza 2.5 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1834740968 |
Reference Sets
Trade product unit of use reference set